MyGenomeRx delivers educational information on how an individual's DNA may alter the way they respond to medications. We provide consumers with a more personalized approach by assessing drug-gene interactions. After consumers upload their raw data from at home DNA testing companies like 23andme or ancestry, the MyGenomeRx portal analyzes over 1 million rsIDs, from 2038 different genes and then provides a report that can be used with further guidance by healthcare providers. Most medications are metabolized to facilitate their removal from the body. These chemical transformations can increase or decrease a drug's pharmacological activity. There can be considerable variation in how people metabolize drugs. A person's DNA is an important factor in determining the speed at which they metabolize drugs. If someone has a genetic variant in an enzyme responsible for the metabolism of a drug, it can influence their drug exposure, which in turn may alter their clinical response and/or risk for adverse side effects. By looking at an individual's DNA MyGenomeRx can identify whether they will make more enzyme than other people (ultrarapid metabolizer) or less enzyme than other people (poor metabolizer). Over 90% of people carry at least 1 genetic variant that should prompt a change in dosing or medication. Pharmacogenomics can help determine which medications will be best for you.